Altretamine

六甲蜜胺

Report date: 2022/03/23 14:31:02
NME

Base Information

Drug NameAltretamine
Drug Alias Name六甲密胺HexamethylmelamineHltretaminumAltretaminaHexalen +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsEndometrial NeoplasmsSmall Cell Lung CarcinomaOvarian Neoplasms +[4] 
Global Approved IndicationsEndometrial NeoplasmsSmall Cell Lung CarcinomaOvarian Neoplasms +[4] 
Approved Indications in ChinaEndometrial NeoplasmsSmall Cell Lung CarcinomaOvarian Neoplasms +[4] 
Original Approved Country/TerritoryFrance
Original Approved Date1979/01/01
Country/TerritoryFranceMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Lisheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsEndometrial NeoplasmsSmall Cell Lung CarcinomaOvarian Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL01XX03
Related LinksWikipediaDrugBankKEGG